Pathophysiology of polycystic ovary syndrome. Overview. 1990

Y Taketani
Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Japan.

UI MeSH Term Description Entries
D011085 Polycystic Ovary Syndrome A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading. Stein-Leventhal Syndrome,Polycystic Ovarian Syndrome,Polycystic Ovary Syndrome 1,Sclerocystic Ovarian Degeneration,Sclerocystic Ovaries,Sclerocystic Ovary Syndrome,Ovarian Degeneration, Sclerocystic,Ovarian Syndrome, Polycystic,Ovary Syndrome, Polycystic,Ovary, Sclerocystic,Sclerocystic Ovary,Stein Leventhal Syndrome,Syndrome, Polycystic Ovary,Syndrome, Stein-Leventhal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Taketani
October 1989, Journal of steroid biochemistry,
Y Taketani
April 1989, Akusherstvo i ginekologiia,
Y Taketani
January 2004, Clinical endocrinology,
Y Taketani
February 2011, Journal of pharmacy practice,
Y Taketani
January 2003, Journal de gynecologie, obstetrique et biologie de la reproduction,
Y Taketani
December 1998, American journal of obstetrics and gynecology,
Y Taketani
January 1990, Hormone research,
Y Taketani
May 2017, Nursing standard (Royal College of Nursing (Great Britain) : 1987),
Y Taketani
January 2016, Current pharmaceutical design,
Copied contents to your clipboard!